药物性急性肾损伤的临床特征与结局
该研究基于国际多中心观察性队列 DIRECT,对 314 例 AKI 病例进行临床裁定,其中 271 例(86%)判定为药物性 AKI(DI-AKI)。最常见的致病药物为万古霉素(48.7%)、非甾体抗炎药(18.2%)和哌拉西林/他唑巴坦(17.8%);裁定者间信度 Krippendorff's alpha 为 0.309。多变量模型识别年龄、血管容量、高血糖、感染、脓尿、血肌酐趋势和造影剂为显著预测因子,ROC AUC 0.86。
要点
- 万古霉素(48.7%)、非甾体抗炎药(18.2%)和哌拉西林/他唑巴坦(17.8%)是常见致病药物。
- DI-AKI 临床裁定者间信度较低,Krippendorff's alpha 为 0.309。
- 多变量模型对 DI-AKI 预测性能良好,ROC AUC 0.86。
核心结论
- 即使由经验丰富的肾脏科医生综合裁定,DI-AKI 的识别仍具挑战性。
- 分析识别了 DI-AKI 与其他 AKI 病因相比的关键临床特征和结局。
研究设计与样本
- 国际多中心观察性队列研究(DIRECT,NCT02159209),纳入临床裁定的富集 DI-AKI 病例。
- 共 314 例 AKI 病例符合分析资格,其中 271 例(86%)裁定为 DI-AKI。
- 多数 AKI 病例招募自美国(68%)。
主要发现
- 最常见的致病药物为万古霉素(48.7%)、非甾体抗炎药(18.2%)和哌拉西林/他唑巴坦(17.8%)。
- DI-AKI 裁定的者间信度 Krippendorff's alpha 为 0.309。
- 多变量模型识别年龄、血管容量、高血糖、感染、脓尿、血肌酐趋势和造影剂为 DI-AKI 的显著预测因子,模型性能良好(ROC AUC 0.86)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Drug-induced acute kidney injury (DI-AKI) is a frequent adverse event. The identification of DI-AKI is challenged by competing etiologies, clinical heterogeneity among patients, and a lack of accurate diagnostic tools. Our research aims to describe the clinical characteristics and predictive variables of DI-AKI. METHODS: We analyzed data from the Drug-Induced Renal Injury Consortium (DIRECT) study (NCT02159209), an international, multicenter, observational cohort study of enriched clinically adjudicated DI-AKI cases. Cases met the primary inclusion criteria if the patient was exposed to at least 1 nephrotoxic drug for a minimum of 24 hours prior to AKI onset. Cases were clinically adjudicated, and inter-rater reliability (IRR) was measured using Krippendorff's alpha. Variables associated with DI-AKI were identified using L1 regularized multivariable logistic regression. Model performance was assessed using the area under the receiver operating characteristic curve (ROC AUC). RESULTS: A total of 314 AKI cases met the eligibility criteria for this analysis, and 271 (86%) cases were adjudicated as DI-AKI. The majority of the AKI cases were recruited from the United States (68%). The most frequent causal nephrotoxic drugs were vancomycin (48.7%), nonsteroidal antiinflammatory drugs (18.2%), and piperacillin/tazobactam (17.8%). The IRR for DI-AKI adjudication was 0.309. The multivariable model identified age, vascular capacity, hyperglycemia, infections, pyuria, serum creatinine (SCr) trends, and contrast media as significant predictors of DI-AKI with good performance (ROC AUC 0.86). CONCLUSION: The identification of DI-AKI is challenging even with comprehensive adjudication by experienced nephrologists. Our analysis identified key clinical characteristics and outcomes of DI-AKI compared to other AKI etiologies.
引用
- Yousif ZK, Koola JD, Macedo E, et al. Clinical Characteristics and Outcomes of Drug-Induced Acute Kidney Injury Cases. Kidney Int Rep. 2023. PMID: 38025217. doi:10.1016/j.ekir.2023.07.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。